1. Home
  2. WST vs RVMD Comparison

WST vs RVMD Comparison

Compare WST & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

HOLD

Current Price

$331.30

Market Cap

25.6B

Sector

Health Care

ML Signal

HOLD

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$189.18

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WST
RVMD
Founded
1923
2014
Country
United States
United States
Employees
N/A
883
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.6B
30.1B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
WST
RVMD
Price
$331.30
$189.18
Analyst Decision
Buy
Strong Buy
Analyst Count
7
19
Target Price
$325.86
$140.84
AVG Volume (30 Days)
726.5K
2.1M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
0.30%
N/A
EPS Growth
1.49
N/A
EPS
4.07
N/A
Revenue
$2,886,900,000.00
N/A
Revenue This Year
$6.76
N/A
Revenue Next Year
$6.22
$533.02
P/E Ratio
$81.39
N/A
Revenue Growth
1.95
N/A
52 Week Low
$223.83
$34.00
52 Week High
$386.00
$194.56

Technical Indicators

Market Signals
Indicator
WST
RVMD
Relative Strength Index (RSI) 38.40 60.66
Support Level $321.94 $176.00
Resistance Level $336.82 $193.83
Average True Range (ATR) 11.14 6.99
MACD -4.53 -1.05
Stochastic Oscillator 8.30 65.41

Price Performance

Historical Comparison
WST
RVMD

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

Share on Social Networks: